A carregar...
Chronic myelogenous leukemia: molecular monitoring in clinical practice
<p>Use of tyrosine kinase inhibitor imatinib has led to significant progress in chronic myeloid leukemia (CML) treatment. To date, genetic monitoring is a mandatory attribute of therapy with tyrosine kinase inhibitors. The purpose of this study was to access the imatinib therapy efficacy in CM...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
ABV-press
2014-07-01
|
| Colecção: | Onkogematologiâ |
| Assuntos: | |
| Acesso em linha: | http://oncohematology.abvpress.ru/index.php/ongm/article/view/39 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|